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Background: There is emerging evidence for the presence of an extensive microbiota in human lungs. It is not
known whether variations in the prevalence of species of microbiota in the lungs may have aetiological significance
in respiratory conditions such as asthma. The aim of the study was to undertake semi-quantitative analysis of the
differences in fungal species in pooled sputum samples from asthma patients and controls.
Methods: Induced sputum samples were collected in a case control study of asthma patients and control subjects
drawn from the community in Wandsworth, London. Samples from both groups were pooled and then tested for
eukaryotes. DNA was amplified using standard PCR techniques, followed by pyrosequencing and comparison of
reads to databases of known sequences to determine in a semi-quantitative way the percentage of DNA from
known species in each of the two pooled samples.
Results: A total of 136 fungal species were identified in the induced sputum samples, with 90 species more
common in asthma patients and 46 species more common in control subjects. Psathyrella candolleana, Malassezia
pachydermatis, Termitomyces clypeatus and Grifola sordulenta showed a higher percentage of reads in the sputum of
asthma patients and Eremothecium sinecaudum, Systenostrema alba, Cladosporium cladosporioides and
Vanderwaltozyma polyspora showed a higher percentage of reads in the sputum of control subjects. A statistically
significant difference in the pattern of fungi that were present in the respective samples was demonstrated using
the Phylogenetic (P) test (P < 0.0001).
Conclusion: This study is novel in providing evidence for the widespread nature of fungi in the sputum of healthy
and asthmatic individuals. Differences in the pattern of fungi present in asthma patients and controls merit further
investigation. Of particular interest was the presence of Malassezia pachydermatis, which is known to be associated
with atopic dermatitis.
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The human lung has a surface area of around 50 m2 [1]
and is in contact with more than 15,000 litres of air each
day [2]. At each breath around 5,000 particles of dust
are inhaled [3]. On average, the dust in the earth’s at-
mosphere contains 10,000 to 100,000 organisms per
gram of dust [4], some of which is in the ‘respirable dust’* Correspondence: vanwoerdenh1@cf.ac.uk; gregoryc1@cf.ac.uk
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distribution, and reproduction in any mediumfraction, consisting of particles smaller than 5 μm [5].
This extensive exposure to the environment means that
the lungs are a common portal for infection by viruses,
bacteria, fungi, protozoa and other infectious agents.
Historically, healthy lungs were believed to be free of
bacteria and that during infection organisms “gain a
foothold in the normally sterile lung tissue” [6]. How-
ever, there is increasing evidence that microbiota are
present even in healthy lungs [7]. This finding raises the
possibility of a potential overlap between pathogenic and
commensal microbiota in the respiratory tract.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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in human lungs. Tunney et al. [8] showed that approxi-
mately 50% of healthy individuals harbour between 1000
and 10,000 culturable anaerobic bacteria per ml of
induced sputum A range of microbial species were also
found in induced sputum at low numbers in another study
which examined sputum from healthy subjects [9]. One
previous study has been identified which used metage-
nomic culture independent genomic techniques and
demonstrated that microbial communities in asthmatic
airways were disordered, with pathogenic Proteobacteria
more frequently found in the bronchi of asthmatics
patients than in controls [10].
The current study further examines the role of atypical
microbiota in respiratory disease. The study used mo-
lecular techniques to identify eukaryote species that
were present in induced sputum samples taken from
asthma patients and controls, living in Wandsworth,
London. The aim of the study was to undertake semi-
quantitative analysis of the differences in fungal species
present in pooled sputum samples from asthma patients
and controls.
Methods
Study population
The study protocol was approved by Camden and Isling-
ton community local research ethics committee (ref 08/
H0722/540). All patients participating in the study sup-
plied informed consent. This case control study from
which the induced sputum samples were drawn has pre-
viously been described. Further information on the char-
acteristics of the subjects in this study has been provided
in that paper [11]. In summary, participants were resi-
dents of Wandsworth, London, and were primarily iden-
tified from the patient registers of two GP practices.
Asthma patients were defined as those individuals who
had a current diagnosis of asthma, for example, by being
on the GP practice asthma register. Most of the asthma
patients were on inhaled corticosteroids. Non-atopic
controls were defined as individuals who on questioning
did not report having current or previous asthma, ec-
zema or hay fever. All participants competed a published
questionnaire [12] to assess the risk of mould in the
home. The questionnaire contained four questions: Is
there any visible mould growth on your house? Is there
any odour of mould or cellar-like musty air in your
house? Is there any moisture stains in your house? Is
there any water/moisture damage in your house?
Sputum collection and DNA extraction
Participants inhaled isotonic saline via an ultrasonic nebu-
liser. Globules of sputum were coughed up into petri
dishes, spread on microscope slides and stained for micro-
scopic examination. Approximately 5 mm2 areas wereexcised from each microscope slide. The samples were
combined to yield two pooled samples for subsequent
DNA extraction and PCR: asthma patients and control
subjects. (A sample from one asthma patient was inadvert-
ently included in the control set). DNA was subsequently
extracted using the Zymo research pinpoint system (Zymo
Research, Irvine, Ca) in accordance with manufacturer’s
instructions. The samples were taken from 30 asthma
patients and 13 non-atopic control subjects involved in
the case control study.
Pyrosequencing of extracted DNA and statistical analysis
Extracted DNA was amplified using a PCR protocol for
the partial 18S rRNA gene using the primer pair (Euk1a
(5’ CTG GTT GAT CCT GCC AG 3’) and Euk516r (5’
ACC AGA CTT GCC CTC C 3’)) in accordance with
previously described protocols [13,14]. The two pooled
extract amplicons, from asthma patients and from con-
trols, were sequenced using a 454 pyrosequencer by Re-
search and Testing Inc, Lubbock, Texas, USA. DNA
sequences were compared to the SILVA database of
known eukaryotic 18S rRNA gene sequences to deter-
mine in a semi-quantitative way the proportional distri-
bution in each of the two samples.
The difference between the pattern of fungal species in
each of the two pooled samples was compared using
Unifrac [15,16]. This online software uses phylogenetic in-
formation to test whether or not two environments are sig-
nificantly different. The software estimates the similarity
between communities by measuring the number of changes
that would be required to explain the differences in the dis-
tribution of sequences between the two environments.
Results
Study population and presence of mould in the home
Patients had a mean age of 41.6 years (SD 14.9, range
18–65 years) and control participants a mean age of 35.7
years (SD 12.8, range 24 – 58 years). The patient group
was 40% male and the control group was 46% male.
A positive answer to at least one of the four questions
regarding possible mould in the home was recorded in
30% (9/30) asthma patients and 15.4% (2/13) of control
subjects. Due to the small sample size, this relatively
large difference was not statistically significant.
Analysis of pyrosequencing data
The differences based on the percent of total DNA reads
of in the pooled samples from asthma patients and non-
atopic controls are shown in Tables 1 and 2. A statisti-
cally significant difference in the pattern of fungi that
were present in the respective samples was demon-
strated using the Phylogenetic (P) test (P <0.0001).
A total of 136 fungal species were identified in the
induced sputum samples, with 90 species more common
Table 1 Fungi that were more common in asthma
patients than in control participants (difference in
percent of DNA reads in descending order)
Fungal species Control
participants
Asthma
patients
Difference
Psathyrella candolleana 0.000 27.294 27.294
Malassezia
pachydermatis
0.000 21.651 21.651
Termitomyces clypeatus 0.000 7.071 7.071
Grifola sordulenta 0.000 4.489 4.489
Pycnoporus sp 0.000 2.938 2.938
Phlebiopsis gigantean 0.000 2.932 2.932
Dichostereum pallescens 0.000 2.746 2.746
Peniophorella
praetermissa
0.168 2.617 2.449
Aspergillus zonatus 0.016 1.959 1.942
Acanthophysium
cerussatum
0.000 1.825 1.825
Pleurotus ostreatus 0.000 1.615 1.615
Candelabrochaete
africana
0.016 1.556 1.540
Basidiobolus ranarum 0.000 1.510 1.510
Tapinella atrotomentosa 0.000 1.487 1.487
Pleurocybella porrigens 0.000 1.399 1.399
Debaryomyces hansenii 0.000 1.294 1.294
Collybia tuberosa 0.000 1.282 1.282
Galerina atkinsoniana 0.000 1.230 1.230
Punctularia
strigosozonata
0.000 1.148 1.148
Elderia arenivaga 0.000 1.143 1.143
Pseudoarmillariella
ectypoides
0.000 0.834 0.834
Pulcherricium caeruleum 0.000 0.665 0.665
Tilletia goloskokovii 0.000 0.618 0.618
Cerrena sp 0.000 0.600 0.600
Serpula lacrymans 0.000 0.571 0.571
Bondarcevomyces taxi 0.000 0.554 0.554
Resinicium bicolor 0.000 0.519 0.519
Cortinarius sodagnitus 0.000 0.414 0.414
Trichaptum abietinum 0.000 0.315 0.315
Chamaeota sinica 0.000 0.262 0.262
Peziza vesiculosa 0.000 0.239 0.239
Pterula echo 0.000 0.204 0.204
Laccocephalum mylittae 0.000 0.198 0.198
Coprinopsis cinerea 0.000 0.198 0.198
Exidiopsis calcea 0.000 0.187 0.187
Dioszegia fristingensis 0.000 0.157 0.157
Inonotus baumii 0.060 0.210 0.150
Hydnochaete olivacea 0.000 0.134 0.134
Derxomyces boekhoutii 0.000 0.128 0.128
Xeromphalina
campanella
0.000 0.117 0.117
Table 1 Fungi that were more common in asthma
patients than in control participants (difference in
percent of DNA reads in descending order) (Continued)
Pulchromyces fimicola 0.000 0.111 0.111
Aspergillus oryzae 0.000 0.099 0.099
Entoloma prunuloides 0.000 0.099 0.099
Dioszegia zsoltii 0.000 0.093 0.093
Basidiobolus haptosporus 0.000 0.087 0.087
Saccharomycopsis
fibuligera
0.000 0.087 0.087
Galiella rufa 0.000 0.082 0.082
Derxomyces simaoensis 0.000 0.070 0.070
Mycoclelandia arenacea 0.000 0.064 0.064
Steccherinum fimbriatum 0.000 0.064 0.064
Austropaxillus sp 0.000 0.058 0.058
Meyerozyma
guilliermondii
0.000 0.058 0.058
Volvariella caesiotincta 0.000 0.058 0.058
Galerina marginata 0.000 0.052 0.052
Occultifur externus 0.000 0.052 0.052
Hericium americanum 0.000 0.047 0.047
Penicillium commune 0.000 0.041 0.041
Volvopluteus earlei 0.000 0.041 0.041
Gymnopus dryophilus 0.000 0.029 0.029
Aspergillus terreus 0.000 0.023 0.023
Tritirachium sp 0.000 0.023 0.023
Gloiocephala aquatic 0.000 0.023 0.023
Tricholoma matsutake 0.000 0.023 0.023
Exidia uvapsassa 0.000 0.017 0.017
Rhodocollybia maculate 0.000 0.017 0.017
Lentinus sp 0.000 0.017 0.017
Teratosphaeria
acidotherma
0.076 0.093 0.017
Taphrina deformans 0.000 0.012 0.012
Antrodia vaillantii 0.000 0.012 0.012
Aspergillus penicillioides 0.000 0.012 0.012
Passalora vaginae 0.000 0.012 0.012
Malassezia furfur 0.000 0.012 0.012
Candida sp 0.000 0.012 0.012
Piromyces sp 0.000 0.012 0.012
Paxillus vernalis 0.000 0.012 0.012
Derxomyces mrakii 0.000 0.012 0.012
Lasiodiplodia gonubiensis 0.000 0.012 0.012
Teratosphaeria ohnowa 0.005 0.012 0.006
Diversispora celata 0.000 0.006 0.006
Geomyces destructans 0.000 0.006 0.006
Coprinopsis sp 0.000 0.006 0.006
Chlamydosauromyces
punctatus
0.000 0.006 0.006
Mortierella minutissima 0.000 0.006 0.006
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Table 2 Fungi that were more common in control
participants than in asthma patients (difference in
percent of DNA reads in descending order)
Fungal species Control
participants
Asthma
patients
Difference
Eremothecium sinecaudum 41.319 1.026 40.293
Systenostrema alba 23.587 0.000 23.587
Cladosporium
cladosporioides
14.484 0.111 14.374
Vanderwaltozyma polyspora 6.778 0.140 6.638
Entophlyctis helioformis 2.976 0.064 2.912
Rozella allomycis 3.009 0.198 2.811
Protomyces macrosporus 1.971 0.082 1.890
Mortierella verticillata 1.135 0.000 1.135
Pseudotaeniolina globosa 1.086 0.210 0.876
Dothidea ribesia 0.701 0.000 0.701
Sporobolomyces
yunnanensis
0.549 0.006 0.543
Teratosphaeria mexicana 0.261 0.000 0.261
Myriangium duriaei 0.179 0.000 0.179
Phaeobotryosphaeria visci 0.174 0.000 0.174
Kionochaeta sp 0.152 0.012 0.140
Catenulostroma
chromoblastomycosum
0.157 0.017 0.140
Phaeobotryon mamane 0.125 0.000 0.125
Allomyces arbuscula 0.125 0.000 0.125
Schizothyrium pomi 0.109 0.000 0.109
Mycosphaerella endophytica 0.103 0.000 0.103
Penidiella columbiana 0.098 0.000 0.098
Aspergillus fumigatus 0.174 0.087 0.086
Cladosporium sp 0.081 0.000 0.081
Aleuria aurantia 0.054 0.000 0.054
Ascodesmis sphaerospora 0.049 0.000 0.049
Penicillium decumbens 0.043 0.000 0.043
Metschnikowia bicuspidata 0.027 0.000 0.027
Dothidea insculpta 0.016 0.000 0.016
Dendryphiella arenaria 0.016 0.000 0.016
Aigialus rhizophorae 0.011 0.000 0.011
Scutellospora spinosissima 0.011 0.000 0.011
Volvariella volvacea 0.011 0.000 0.011
Flammulina velutipes 0.011 0.000 0.011
Candida bituminiphila 0.005 0.000 0.005
Ascobolus carbonarius 0.005 0.000 0.005
Cyttaria sp 0.005 0.000 0.005
Halosarpheia japonica 0.005 0.000 0.005
Phymatotrichopsis omnivora 0.005 0.000 0.005
Sporobolomyces sp 0.005 0.000 0.005
Orphella haysii 0.005 0.000 0.005
Coccocarpia erythroxyli 0.005 0.000 0.005
Termitaria sp 0.005 0.000 0.005
Table 1 Fungi that were more common in asthma
patients than in control participants (difference in
percent of DNA reads in descending order) (Continued)
Saccobolus dilutellus 0.000 0.006 0.006
Thanatephorus fusisporus 0.000 0.006 0.006
Boletellus shichianus 0.000 0.006 0.006
Puccinia poarum 0.000 0.006 0.006
Mallocybe dulcamara 0.000 0.006 0.006
Coniophora marmorata 0.000 0.006 0.006
Trichosporon sp 0.000 0.006 0.006
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trol subjects, based on the percent of total DNA reads
(see Figure 1). Psathyrella candolleana, Malassezia pachy-
dermatis, Termitomyces clypeatus and Grifola sordulenta
were particularly prevalent in the sputum of asthma
patients and Eremothecium sinecaudum, Systenostrema
alba, Cladosporium cladosporioides and Vanderwaltozyma
polyspora were particularly prevalent in the sputum of con-
trol subjects. No other eukaryote species were identified in
the sputum samples.
Discussion
The range of fungal species present in both asthma
patients and control subjects was larger than expected.
There were also clear differences in the pattern of fun-
gal species between asthma patients and control sub-
jects. The fungi Malassezia pachydermatis, was found
in patients with asthma and not the control group.
This organism has a known association with atopic
conditions including atopic dermatitis [17]. However,
there were no other obvious associations were identi-
fied in the published literature between asthma and
the other fungi found in the pooled samples from the
asthma patients. Two of the fungi most commonly
found in the sputum of asthma patients (Termitomyces
clypeatus and Psathyrella candolleana) represent mem-
bers of the basidiomycete family [18]. The latter has
been found in indoor dust [19] and one can speculate
that fungal spores may have been inhaled within the
home. It is possible that most of the fungi identified
could have come from a single individual, or a small
number of individuals, whose samples were heavily
colonised by fungi.
Except for Cladosporium, the species identified in
induced sputum are not commonly found in air samples
examined using standard culture techniques [20]. Ana-
lysis of air samples using molecular techniques may
demonstrate that these species are commonly present in
the air, but this research has not been undertaken so far.
Three out of four species detected in the sputum of
asthma patients were from the macromycetes group
(commonly known as mushrooms). Although asthma is
Table 2 Fungi that were more common in control
participants than in asthma patients (difference in
percent of DNA reads in descending order) (Continued)
Candida glabrata 0.005 0.000 0.005
Schizosaccharomyces
japonicus
0.005 0.000 0.005
Cladochytrium sp 0.005 0.000 0.005
Cyttaria hookeri 0.011 0.006 0.005
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mould growth, we are unaware of any study that has
identified an association between macromycetes and
asthma. Future studies should consider analysing air
samples from the homes of participants using molecular
techniques, so as to take into account the presence of
fungi in the ambient environment of participants.
We used universal primers for the eukaryotic 18S rRNA
gene and were surprised that no eukaryotes other than
fungi were identified in cases or controls. We have consid-
ered a number of potential reasons why this may be the
case and the most likely was that levels of non-fungal
eukaryotic DNA, present in the samples, was below the
limits of detection. The PCR primers were chosen after
considerable deliberation and a probeCheck test showed
that they were universal and matched Homo sapiens’ 18S
rRNA gene 100% [21]. However other potential reasons
include: a genuine absence of other eukaryotes and45 35 25 15 5
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Figure 1 Graph showing the percentage of pyrosequencing reads for
participant (C) samples (species identified for reads greater than 1%)unintended removal of DNA from other eukaryotes as
part of the processing of the samples.
Individual level analysis of samples was considered,
but rejected as it was anticipated that, if the samples
from each individual were analysed separately, the num-
ber of eukaryotes in each sample would be below the
threshold of detection. Samples for this study were
therefore pooled to maximise the number of copies of
each species in the pooled samples and consequently
maximise the probability of detecting all the species that
were present.
The study has a number of weaknesses. The sputum
was not fresh when it was examined and although every
effort was made to prevent contamination of samples by
spores in the air, this is a possibility. The sample size is
small and therefore may not be representative of asthma
patients. Unfortunately, information on pets was not col-
lected in this study and therefore could not be correlated
with the presence of absence of particular fungi. It is
possible to speculate that the presence of a pet (particu-
larly a dog) in the subjects' house might be associated
with the presence of Malassezia pachydermatis in the
sputum of the research subjects, as this organism has
been identified as a commensal on the skin of dogs and
have could contaminated air in the homes of some of
the research participants.
The potential significance of these fungi is unclear.
There is tentative emerging evidence that microbiota5 15 25 35 45
Eremothecium sinecaudum
 reads in A
fungal species identified in the Asthma patient (A) or control
.
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disease, for example, by their effects on the immune sys-
tem, without becoming pathogenic in the classical sense.
For example, microbial compounds present in sputum
may play a role as adjuvant factors and encourage a
Th2-biased allergic response [22,23].
Conclusion
This study provides emerging evidence for the wide-
spread presence of fungi in the sputum of asthma
patients and control subjects. Significant differences
have been identified in the pattern of fungi present in
asthma patients and control subjects drawn from the
same community. Although this method demonstrates
the possibility of using microscopy samples, further in-
vestigation is warranted which applies these techniques
to fresh sputum samples. This method may in itself be
applicable to analysis of historical samples and may in
turn prove of interest in evaluating the microbiome of
the lung demographically and between generations.
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